We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
MedXY AI/MedXY News/Neurology

Neurology

Ask MedXY AI
What is the latest evidence?Key clinical updatesGuideline changes

Latest news

Evaluating Tirofiban Plus Aspirin in Branch Atheromatous Disease Stroke: Insights from the STRATEGY Trial
NeurologystrokeBranch Atheromatous Disease

Evaluating Tirofiban Plus Aspirin in Branch Atheromatous Disease Stroke: Insights from the STRATEGY Trial

By MedXY|Sep 5, 2026

The STRATEGY trial assessed whether combining tirofiban with aspirin improves outcomes in branch atheromatous disease (BAD)-related stroke but found no significant benefit over aspirin alone in preventing neurological deterioration or recur

Safety and Efficacy of Guanabenz in Early-Childhood Onset Vanishing White Matter: Insights from a Phase 1/2 Single-Arm Trial
Clinical Updatesvanishing white matterpediatric neurodegeneration

Safety and Efficacy of Guanabenz in Early-Childhood Onset Vanishing White Matter: Insights from a Phase 1/2 Single-Arm Trial

By MedXY|Sep 5, 2026

This review synthesizes recent evidence demonstrating guanabenz’s manageable safety profile and efficacy in delaying ambulatory decline in early-onset vanishing white matter disease, highlighting translational pharmacokinetic data and

Antiseizure Medication Use During Pregnancy: Implications for Fetal Growth from the EURAP Registry
NeurologyTăng trưởng thai nhiPregnancy

Antiseizure Medication Use During Pregnancy: Implications for Fetal Growth from the EURAP Registry

By MedXY|Sep 5, 2026

A comprehensive cohort study from the EURAP registry reveals that antiseizure medication, especially polytherapy and certain monotherapies, increases the risk of poor fetal growth, underscoring the need for optimized treatment strategies du

Revolutionizing Stroke Diagnosis: Noninvasive Thrombus Imaging with [18F]GP1 PET/CT
Neurology[18F]GP1 PETStroke Etiology

Revolutionizing Stroke Diagnosis: Noninvasive Thrombus Imaging with [18F]GP1 PET/CT

By MedXY|Sep 5, 2026

A novel noninvasive imaging technique using [18F]GP1 PET/CT enables direct identification of thrombi in acute ischemic stroke, improving etiologic classification and predicting recurrence risk, heralding mechanism-based stroke management.

Prenatal Organophosphate Exposure and Autism Traits: A Large-Scale Cohort Study Finds No Association
Neurologyorganophosphatechild neurodevelopment

Prenatal Organophosphate Exposure and Autism Traits: A Large-Scale Cohort Study Finds No Association

By MedXY|Sep 4, 2026

This large prospective cohort study found no significant association between prenatal organophosphate pesticide exposure and autism-related traits in children, after comprehensive adjustments including maternal diet and sociodemographic fac

Cherry Angiomas as a Novel Vascular Manifestation in Neurofibromatosis Type 1: Epidemiology and Mechanistic Insights
DermatologyCherry Angiomasneurofibromatosis type 1

Cherry Angiomas as a Novel Vascular Manifestation in Neurofibromatosis Type 1: Epidemiology and Mechanistic Insights

By MedXY|Sep 3, 2026

Cherry angiomas are significantly more prevalent and occur at younger ages in individuals with Neurofibromatosis Type 1 (NF1), linked to biallelic NF1 inactivation in vascular cells. This discovery expands the vascular phenotype of NF1 and

Metabolite-Mediated Neurocognitive Revival Following Liver Transplantation: Insights into Cortical Network Reactivation
GastroenterologyNeuroinflammationNeurocognitive Recovery

Metabolite-Mediated Neurocognitive Revival Following Liver Transplantation: Insights into Cortical Network Reactivation

By MedXY|Sep 3, 2026

Liver transplantation facilitates early neurocognitive recovery in end-stage liver disease patients by restoring cortical network activities, with S-methyl-5′-thioadenosine playing a pivotal neuroprotective role through modulating neu

Variable Effects of Vagus Nerve Stimulator Cycling on Vocal Fold Motion: A Videographic Case Series
Neurologydysphoniavocal fold motion

Variable Effects of Vagus Nerve Stimulator Cycling on Vocal Fold Motion: A Videographic Case Series

By MedXY|Aug 31, 2026

This case series examines eight patients experiencing dysphonia after vagus nerve stimulator placement, highlighting variable and transient vocal fold motion changes during device cycling.

Recent Mechanical Venous Thrombosis Risk Factors and Their Role in Young-Onset Cryptogenic Ischemic Stroke: New Insights from the SECRETO Study
Hematology-Oncologycryptogenic ischemic strokevenous thrombosis risk factors

Recent Mechanical Venous Thrombosis Risk Factors and Their Role in Young-Onset Cryptogenic Ischemic Stroke: New Insights from the SECRETO Study

By MedXY|Aug 31, 2026

This multicenter study reveals that recent mechanical venous thrombosis risk factors markedly increase the risk of cryptogenic ischemic stroke in young adults, especially in those under 40 and with patent foramen ovale, independent of throm

What is the Elderly Mobility Scale Calculator?
Neurologycalculatorelderly mobility scale

What is the Elderly Mobility Scale Calculator?

By MedXY|Aug 30, 2026

The elderly mobility scale calculator (EMS calculator) is a validated clinical assessment tool designed specifically to evaluate functional mobility i

Recent Mechanical Venous Thrombosis Risk Factors and Their Role in Young-Onset Cryptogenic Ischemic Stroke
Hematology-Oncologycryptogenic ischemic strokemechanical risk factors

Recent Mechanical Venous Thrombosis Risk Factors and Their Role in Young-Onset Cryptogenic Ischemic Stroke

By MedXY|Aug 29, 2026

This multicenter study reveals that recent mechanical venous thrombosis risk factors within 14 days significantly increase the risk of cryptogenic ischemic stroke in young adults, notably in those under 40 and with patent foramen ovale, ind

RNF213 p.R4810K Variant: A Novel Independent Genetic Risk Factor for Extracranial Carotid Artery Disease
CardiologyExtracranial Carotid Artery DiseaseIntracranial Atherosclerotic Disease

RNF213 p.R4810K Variant: A Novel Independent Genetic Risk Factor for Extracranial Carotid Artery Disease

By MedXY|Aug 29, 2026

The RNF213 p.R4810K variant independently increases risk and severity of extracranial carotid artery disease, distinct from its known association with intracranial atherosclerosis, highlighting new insights into vascular disease genetics an

Unraveling White Matter Hyperintensities: Distinct Lesion Subtypes Reveal Diverse Clinical Implications Beyond Location
Neurologycerebrovascular diseaselesion subtypes

Unraveling White Matter Hyperintensities: Distinct Lesion Subtypes Reveal Diverse Clinical Implications Beyond Location

By MedXY|Aug 29, 2026

Advanced MRI analyses identify three biologically distinct subtypes of white matter hyperintensities (WMHs), linking specific lesion evolution patterns with neurodegeneration and vascular/metabolic risks, offering refined insights into cere

Severe Parsonage-Turner Syndrome vs. Traumatic Brachial Plexopathy: Insights into Motor Recovery and Treatment Outcomes
Neurologyfunctional recoveryMotor Reinnervation

Severe Parsonage-Turner Syndrome vs. Traumatic Brachial Plexopathy: Insights into Motor Recovery and Treatment Outcomes

By MedXY|Aug 29, 2026

This study compares motor-unit reinnervation and functional recovery in severe Parsonage-Turner syndrome and surgically managed traumatic brachial plexopathy, highlighting spontaneous recovery in PTS and benefits of early reconstruction in

Higher Stroke and TIA Risk With Pulsed Field Ablation Compared to Radiofrequency Ablation in Atrial Fibrillation: Insights From a Large Prospective Registry
Cardiologyatrial fibrillationPulsed-field ablation

Higher Stroke and TIA Risk With Pulsed Field Ablation Compared to Radiofrequency Ablation in Atrial Fibrillation: Insights From a Large Prospective Registry

By MedXY|Aug 27, 2026

This prospective registry reveals a significantly increased risk of stroke or transient ischemic attack within 30 days after pulsed field ablation compared to radiofrequency ablation for atrial fibrillation, highlighting important safety co

Unveiling Neuroimaging Patterns and Genotype-Phenotype Links in Noonan Syndrome: Insights from a Multicenter Cohort
Diabetes & EndocrinologyBrain MRIRAS/MAPK pathway

Unveiling Neuroimaging Patterns and Genotype-Phenotype Links in Noonan Syndrome: Insights from a Multicenter Cohort

By MedXY|Aug 28, 2026

A comprehensive multicenter study reveals frequent neuroimaging abnormalities in children with Noonan syndrome and elucidates their associations with genetic variants and neurological symptoms, enhancing understanding of brain involvement i

Expanding Horizons: Eligibility and Implications of Thrombolysis in Pediatric Acute Ischemic Stroke
NeurologytPAThrombolysis

Expanding Horizons: Eligibility and Implications of Thrombolysis in Pediatric Acute Ischemic Stroke

By MedXY|Aug 28, 2026

This study evaluates the eligibility of children with acute ischemic stroke (AIS) for thrombolysis with tPA, revealing only 19% potential eligibility under current guidelines, and highlights opportunities to reconsider treatment in small-ve

MRI-Derived EOAD-Signature Atrophy as a Prognostic Biomarker in Early-Onset Mild Cognitive Impairment
NeurologyEarly-Onset Alzheimer Diseasemild cognitive impairment

MRI-Derived EOAD-Signature Atrophy as a Prognostic Biomarker in Early-Onset Mild Cognitive Impairment

By MedXY|Aug 28, 2026

Baseline cortical atrophy within an EOAD-specific brain signature predicts progression from mild cognitive impairment to dementia, providing a valuable MRI biomarker for individualized prognosis in early-onset Alzheimer disease.

Body Weight and Alteplase Efficacy in Acute Ischemic Stroke: Insights from the ENCHANTED Trial
Critical CareENCHANTED trialThrombolysis

Body Weight and Alteplase Efficacy in Acute Ischemic Stroke: Insights from the ENCHANTED Trial

By MedXY|Aug 28, 2026

The ENCHANTED trial post hoc analysis reveals body weight does not alter alteplase dose effectiveness in acute ischemic stroke, but low body weight independently predicts poorer outcomes without increased hemorrhagic risk.

Unveiling Metabolic Signatures: Glucose and Methionine PET Imaging in Disorders of Consciousness Post-Brain Injury
NeurologyFDG-PETBrain Injury

Unveiling Metabolic Signatures: Glucose and Methionine PET Imaging in Disorders of Consciousness Post-Brain Injury

By MedXY|Aug 26, 2026

This exploratory longitudinal study reveals that alongside decreased glucose metabolism, elevated brainstem methionine uptake correlates with consciousness improvement in brain-injured patients, highlighting novel metabolic biomarkers for p

Prev
3 / 25
12345…25
Next
Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities

Browse by specialty

Open language-specific specialty feeds and department pages.

news6629 articlesCardiology1375 articlesClinical Updates1288 articlesOncology1139 articlesDiabetes & Endocrinology842 articlesNeurology820 articlesPublic Health595 articlesGastroenterology572 articles
Hematology-Oncology
487 articles
Pediatrics484 articles
Internal Medicine444 articles